Teradyne price target raised to $136 from $125 at Northland

Northland raised the firm’s price target on Teradyne to $136 from $125 and keeps an Outperform rating on the shares. AI is increasing test capacity utilization and absorbing excess mobile test capacity and Teradyne is starting to benefit, says the analyst, who is increasing the firm’s 2024 and 2025 estimates based on higher semi test revenue.